呼吸器外科

Keyphrases

1. 3D Printing System 50%
2. Acute Phase 20%
3. Adipokinetic Hormone 50%
4. Adipose-derived Mesenchymal Stem Cells (ADMSCs) 50%
5. Adipose-derived MSCs 100%
6. Adjuvant Chemotherapy 50%
7. Adverse Reactions 20%
8. Air Leak 50%
9. Anticancer Agents 50%
10. Antioxidant System 50%
11. Autologous Blood 50%
12. Barrier Function 50%
13. Bio 3D Printing 50%
14. Biological Antioxidant Potential 40%
15. Chest Wall 50%
16. Cisplatin 50%
17. Clustering Approach 50%
18. Complex Segmentectomy 28%
19. Concurrent Chemoradiotherapy 50%
20. Consumer-grade 50%
21. Conventional Therapy 50%
22. Conventional Treatment 20%
23. Critically Ill Patients 50%
24. Deep Learning 50%
25. Deep Surgical Site Infection 20%
26. Descending Necrotizing Mediastinitis 50%
27. Downstream Applications 50%
28. Free-form Structures 50%
29. Grade Estimation 50%
30. Granulocyte Colony-stimulating Factor (G-CSF) 20%
31. Hepatectomy 50%
32. Histopathological Images 16%
33. Human Cells 50%
34. Immunostaining 18%
35. Induction Chemoradiotherapy 50%
36. Internal Cavity 50%
37. Interobserver Variability 58%
38. Irradiation 37%
39. Living-donor Lobar Lung Transplantation (LDLLT) 50%
40. Lobar Lung Transplantation 20%
41. Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) 50%
42. Lung 34%
43. Lung Adenocarcinoma 100%
44. Lung Adenocarcinoma Subtypes 83%
45. Lung Epithelial Cells 50%
46. Lung Transplantation 50%
47. Lymphoid Follicular Hyperplasia 50%
48. Malignant Mesothelioma 50%
49. Malignant Pleural Mesothelioma 50%
50. Mesenchymal Stem Cell Therapy 50%
51. Mesenchymal Stromal Cells 50%
52. Mirogabalin 50%
53. Modified Ratio 30%
54. Multiple Dose 28%
55. Neuropathic Pain 50%
56. New Targets 50%
57. Non-small Cell Lung Cancer (NSCLC) 60%
58. Non-survivors 30%
59. Nude Mouse Model 50%
60. Odontogenic Infection 50%
61. Older Women 18%
62. Oral Fluoropyrimidine 20%
63. Oxidative Stress 30%
64. Pain Research 50%
65. Pathologist 75%
66. Peripheral Neuropathic Pain 50%
67. Phase II Study 50%
68. Pleurodesis 50%
69. Poor Prognostic Factors 50%
70. Postoperative Air Leak 50%
71. Predictive Factors 50%
72. Pro-oxidant 50%
73. Pulmonary Alveolar Proteinosis 50%
74. Pulmonary Resection 35%
75. Radiosensitivity 50%
76. Radiosensitizing Effect 25%
77. Rat Lung 56%
78. Rat Trachea 50%
79. Reactive Oxidant Species 40%
80. Retrospective Cohort Study 50%
81. Scaffold-based 18%
82. Scaffold-free 50%
83. Standardized Classification 50%
84. Stent Simulation 50%
85. Surgical Drainage 20%
86. Surgical Learning 50%
87. Surgical Resection 36%
88. Surgical Site Infection 50%
89. Survivors 20%
90. Thoracic Cavity 20%
91. Thoracic Surgery 50%
92. Thymidine Synthase 50%
93. Total-body 25%
94. Trachea 50%
95. Training Model 25%
96. Transplantation 20%
97. Tumor 20%
98. Vessel Invasion 50%

Medicine and Dentistry

1. Adipose Tissue 50%
2. Adipose-Derived Mesenchymal Stem Cell 50%
3. Adjuvant Chemotherapy 50%
4. Adverse Event 24%
5. Angiofollicular Lymph Node Hyperplasia 8%
6. Anticarcinogen 50%
7. Aortic Valve Replacement 8%
8. Asbestos Exposure 12%
9. Autoantibodies 10%
10. Back 12%
11. Benign Tumor 8%
12. Cancer 8%
13. Cell Proliferation 12%
14. Chemoradiotherapy 50%
15. Chemotherapy 14%
16. Chronic Pain 10%
17. Cisplatin 50%
18. Combination Therapy 14%
19. Computer Assisted Tomography 25%
20. Diagnosis 22%
21. Disease 12%
22. Disease Specific Survival 10%
23. Drainage Procedure 8%
24. Glomerulonephritis 8%
25. Granulocyte Macrophage Colony Stimulating Factor 20%
26. Health Care Cost 16%
27. Hemodialysis 16%
28. Hepatectomy 50%
29. Hypoxia Inducible Factor 1 12%
30. Immunohistochemistry 17%
31. Immunosuppressive Drug 20%
32. Immunosuppressive Treatment 10%
33. Infection 25%
34. Inhalational Drug Administration 10%
35. Learning Curve 50%
36. Living Donors 50%
37. Lung 37%
38. Lung Adenocarcinoma 100%
39. Lung Alveolus Proteinosis 50%
40. Lung Cancer Cell Line 12%
41. Lung Lavage 10%
42. Lung Transplantation 100%
43. Lymphoid Hyperplasia 50%
44. Lymphoproliferative Disease 16%
45. Mandibular Molar 8%
46. Mediastinitis 50%
47. Mesenchymal Stem Cell 10%
48. Mesenchymal Stem Cell Transplantation 50%
49. Mesothelioma 50%
50. Mesothelioma Cell Line 12%
51. Messenger RNA 12%
52. Mirogabalin 50%
53. Multiple Drug Dose 21%
54. Neck 8%
55. Neoplasm 65%
56. Neuropathic Pain 50%
57. Non Small Cell Lung Cancer 100%
58. Odontogenic Infection 50%
59. Organ Transplantation 10%
60. Oxygen Therapy 10%
61. Pathologist 57%
62. Physical Disease by Body Function 10%
63. Pleura Mesothelioma 50%
64. Pleurodesis 50%
65. Pneumonectomy 35%
66. Predictive Factor 50%
67. Prognostic Factor 50%
68. Programmed Cell Death 12%
69. Propensity Score Matching 9%
70. Prostate Cancer Cell Line 12%
71. Protein Expression 12%
72. Quality of Life 10%
73. Radiation Therapy 19%
74. Radiosensitivity 50%
75. Radiosensitizer 12%
76. Recurrent Disease 24%
77. Retrospective Cohort Study 54%
78. Segmentectomy 50%
79. Single Drug Dose 14%
80. Stenosis 33%
81. Stent Placement 33%
82. Stenting 50%
83. Surgeon 58%
84. Surgery 30%
85. Surgical Drainage 16%
86. Surgical Infection 50%
87. Survival Rate 21%
88. Tacrolimus 10%
89. Thoracic Cavity 20%
90. Thoracic Wall 57%
91. Thorax Surgery 50%
92. Thrombin 14%
93. Treatment Group 15%
94. Trismus 8%
95. Tumor Progression 12%
96. UFT 14%
97. Vascular Tissue Neoplasm 12%
98. Video-Assisted Thoracoscopic Surgery 50%
99. Visual Analog Scale 15%
100. Xenograft 12%